BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 17412280)

  • 1. FDG-PET CT for tumor imaging.
    Miller JC; Fischman AJ; Aquino SL; Blake MA; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Apr; 4(4):256-9. PubMed ID: 17412280
    [No Abstract]   [Full Text] [Related]  

  • 2. How do we best balance optimal timing of FDG PET-CT imaging?
    Hofman MS; O'Doherty M
    Nucl Med Commun; 2007 Dec; 28(12):885-7. PubMed ID: 18090212
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of 99mTc-sestamibi scintigraphy in multiple myeloma.
    Pace L; Salvatore M; Del Vecchio S
    J Nucl Med; 2006 Mar; 47(3):555. PubMed ID: 16513630
    [No Abstract]   [Full Text] [Related]  

  • 5. Added value of PET and PET-computed tomography in oesophageal cancer: a review of current practice.
    Douis H; Jafri M
    Nucl Med Commun; 2008 Sep; 29(9):840. PubMed ID: 18677217
    [No Abstract]   [Full Text] [Related]  

  • 6. Recurrent colon cancer involving the urinary bladder identified with F-18 FDG PET/CT after forced diuresis.
    Chen CJ; Chao TB; Shih DF
    Clin Nucl Med; 2010 Apr; 35(4):258-9. PubMed ID: 20305415
    [No Abstract]   [Full Text] [Related]  

  • 7. PET/CT: challenge for nuclear cardiology.
    Schwaiger M; Ziegler S; Nekolla SG
    J Nucl Med; 2005 Oct; 46(10):1664-78. PubMed ID: 16204717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating pulmonary nodules.
    Miller JC; Shepard JA; Lanuti M; Aquino S; Thrall JH; Lee SI
    J Am Coll Radiol; 2007 Jun; 4(6):422-6. PubMed ID: 17544146
    [No Abstract]   [Full Text] [Related]  

  • 9. Adequate evaluation of image registration in hybrid PET/CT.
    Vogel WV; van Dalen JA; Oyen WJ
    J Nucl Med; 2006 Sep; 47(9):1556; author reply 1557-8. PubMed ID: 16954568
    [No Abstract]   [Full Text] [Related]  

  • 10. Bowel hot spots at PET-CT.
    Prabhakar HB; Sahani DV; Fischman AJ; Mueller PR; Blake MA
    Radiographics; 2007; 27(1):145-59. PubMed ID: 17235004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique presentation of appendicitis: F-18 FDG PET/CT.
    Koff SG; Sterbis JR; Davison JM; Montilla-Soler JL
    Clin Nucl Med; 2006 Nov; 31(11):704-6. PubMed ID: 17053390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined (18)F-FDG and fluoride approach in PET/CT imaging: is there a clinical future?
    Basu S; Rao R
    J Nucl Med; 2010 Jan; 51(1):165; author reply 166-7. PubMed ID: 20008984
    [No Abstract]   [Full Text] [Related]  

  • 13. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDG PET/CT imaging of a gastric fistula.
    Strobel K; Zippelius A; Hany TF
    Clin Nucl Med; 2007 Apr; 32(4):336-7. PubMed ID: 17413593
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography/computed tomography: the current technology and applications.
    Mittra E; Quon A
    Radiol Clin North Am; 2009 Jan; 47(1):147-60. PubMed ID: 19195540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positron emission tomography-computerized tomography findings in a urinary bladder paraganglioma.
    Thambugala GM; Fulham MJ; Mohamed A
    Australas Radiol; 2007 Oct; 51 Spec No.():B45-7. PubMed ID: 17875156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolapsed endometrial cancer: FDG PET/CT findings.
    Kaneta T; Hakamatsuka T; Yamada T; Sato A; Higano S; Fukuda H; Takahashi S; Yamada S
    Clin Nucl Med; 2006 Mar; 31(3):180. PubMed ID: 16495748
    [No Abstract]   [Full Text] [Related]  

  • 18. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult prolactinoma diagnosed by FDG PET/CT.
    Gemmel F; Balink H; Collins J; Oomen P
    Clin Nucl Med; 2010 Apr; 35(4):269-70. PubMed ID: 20305420
    [No Abstract]   [Full Text] [Related]  

  • 20. The Role of 18F-FDG PET/CT in the evaluation of Ascites of Undetermined Origin.
    Zhang M; Jiang X; Zhang M; Xu H; Zhai G; Li B
    J Nucl Med; 2009 Apr; 50(4):506-12. PubMed ID: 19289438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.